819 Capital Partners and LIOF invest in I-Med Technology

Deventer, November 19, 2024 – 819 Capital Partners and LIOF have invested in I-Med Technology (“I-Med”) in a substantial investment round. I-Med Technology develops and markets advanced head-mounted 3D imaging systems that provide real-time support, enhancing precision and efficiency in medical and dental procedures.

Continue reading “819 Capital Partners and LIOF invest in I-Med Technology”

819 Capital Partners acquires Touroperating division from ANWB

Deventer, June 13, 2024 – 819 Capital Partners has acquired the Touroperating division from ANWB through a buy-out, together with the management team Gert-Jan Bressers and Richard Broekhoven. The new organization will continue under the name Fox Reizen and will continue to develop and execute member trips for the ANWB.

Continue reading “819 Capital Partners acquires Touroperating division from ANWB”

819 Capital Partners invests in Sono-Coat in strategic deal with LipoCoat

LipoCoat Holdings (“LipoCoat”), a portfolio company from 819 Capital Partners, strategically acquired Sono-Coat. The deal is backed by a growth investment directly into Sono-Coat BV (“Sono-Coat”) led by 819 Capital Partners (“819”) from their 819 Evergreen Fund.

Continue reading “819 Capital Partners invests in Sono-Coat in strategic deal with LipoCoat”